Published in Best Pract Res Clin Gastroenterol on June 01, 2010
The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology (2013) 3.89
Current status of molecular markers for early detection of sporadic pancreatic cancer. Biochim Biophys Acta (2010) 1.58
Pancreatic stellate cells: a starring role in normal and diseased pancreas. Front Physiol (2012) 1.38
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2012) 1.35
American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas (2014) 1.30
Inflammation and p53: A Tale of Two Stresses. Genes Cancer (2011) 1.27
Early diagnosis of pancreatic cancer: challenges and new developments. Biomark Med (2012) 1.23
Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. Pancreas (2013) 1.15
Risk factors for pancreatic cancer: underlying mechanisms and potential targets. Front Physiol (2014) 1.10
Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia (2011) 1.08
Advances in biomarker research for pancreatic cancer. Curr Pharm Des (2012) 1.05
Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients. J Immunol Res (2014) 1.04
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J Gastroenterol (2014) 1.03
Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing. Genes Dev (2015) 1.00
Complex role for the immune system in initiation and progression of pancreatic cancer. World J Gastroenterol (2014) 1.00
Spontaneous Pancreatitis Caused by Tissue-Specific Gene Ablation of Hhex in Mice. Cell Mol Gastroenterol Hepatol (2015) 0.97
Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br J Cancer (2012) 0.95
Deacetylation by SIRT1 Reprograms Inflammation and Cancer. Genes Cancer (2013) 0.92
Genetic inactivation of the pancreatitis-inducible gene Nupr1 impairs PanIN formation by modulating Kras(G12D)-induced senescence. Cell Death Differ (2014) 0.92
Diabetes, pancreatic cancer, and metformin therapy. Front Physiol (2014) 0.92
Hyperglycemia, a neglected factor during cancer progression. Biomed Res Int (2014) 0.91
Calcium-permeable ion channels in control of autophagy and cancer. Front Physiol (2013) 0.91
Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression. Oncotarget (2015) 0.90
ABO blood group and chronic pancreatitis risk in the NAPS2 cohort. Pancreas (2011) 0.90
The burning question: why is smoking a risk factor for pancreatic cancer? Pancreatology (2012) 0.89
Association between Variants in Atopy-Related Immunologic Candidate Genes and Pancreatic Cancer Risk. PLoS One (2015) 0.89
Association between allergies and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2014) 0.89
Update on the management of pancreatic cancer: surgery is not enough. World J Gastroenterol (2015) 0.89
Risk factors and therapeutic targets in pancreatic cancer. Front Oncol (2013) 0.88
Fibrosis reduces severity of acute-on-chronic pancreatitis in humans. Gastroenterology (2013) 0.87
Strategies for early detection of resectable pancreatic cancer. World J Gastroenterol (2014) 0.86
Impact of microvessel density on lymph node metastasis and survival after curative resection of pancreatic cancer. Surg Today (2011) 0.86
Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors. Cancers (Basel) (2012) 0.85
Discovering the route from inflammation to pancreatic cancer. Minerva Gastroenterol Dietol (2012) 0.85
Pancreatic cancer metastasis: are we being pre-EMTed? Curr Pharm Des (2015) 0.85
Impact of diabetes type II and chronic inflammation on pancreatic cancer. BMC Cancer (2015) 0.84
Metabolic system alterations in pancreatic cancer patient serum: potential for early detection. BMC Cancer (2013) 0.83
Current status and progress of pancreatic cancer in China. World J Gastroenterol (2015) 0.83
Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry. Arch Pathol Lab Med (2014) 0.81
Pancreatic Cancer Genetics. Int J Biol Sci (2016) 0.81
Association studies of the copy-number variable ß-defensin cluster on 8p23.1 in adenocarcinoma and chronic pancreatitis. BMC Res Notes (2012) 0.81
Smad4 loss synergizes with TGFα overexpression in promoting pancreatic metaplasia, PanIN development, and fibrosis. PLoS One (2015) 0.80
Reg3g Promotes Pancreatic Carcinogenesis in a Murine Model of Chronic Pancreatitis. Dig Dis Sci (2015) 0.80
Inflammatory macrophages in pancreatic acinar cell metaplasia and initiation of pancreatic cancer. Oncoscience (2015) 0.80
Characterization of Mouse Models of Early Pancreatic Lesions Induced by Alcohol and Chronic Pancreatitis. Pancreas (2015) 0.80
Early detection of pancreatic cancer. Chin J Cancer Res (2015) 0.80
Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents. Semin Immunopathol (2012) 0.80
Variation in the γ-glutamyltransferase 1 gene and risk of chronic pancreatitis. Pancreas (2013) 0.79
Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer. J Carcinog (2012) 0.79
Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters. World J Gastroenterol (2015) 0.79
Pancreatic ductal adenocarcinoma screening: new perspectives. World J Gastroenterol (2012) 0.79
Pharmacological attenuation of chronic alcoholic pancreatitis induced hypersensitivity in rats. World J Gastroenterol (2015) 0.79
A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review. Am J Gastroenterol (2017) 0.79
Inflammation and pancreatic cancer: disease promoter and new therapeutic target. J Gastroenterol (2013) 0.78
Role of Parathyroid Hormone-Related Protein Signaling in Chronic Pancreatitis. Cancers (Basel) (2015) 0.78
[Pancreatic cancer. Molecular and surgical pathology]. Pathologe (2010) 0.78
Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer. Sci Rep (2015) 0.78
Surveillance for neoplasia in the pancreas. Best Pract Res Clin Gastroenterol (2016) 0.78
Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases. World J Hepatol (2015) 0.78
Complications of Chronic Pancreatitis. Dig Dis Sci (2017) 0.77
Challenges in detecting pre-malignant pancreatic lesions during acute pancreatitis using a serum microRNA assay: a study based on KrasG12D transgenic mice. Oncotarget (2016) 0.77
Pathologic cellular events in smoking-related pancreatitis. Cancers (Basel) (2015) 0.77
Tumor cell expression of MMP3 as a prognostic factor for poor survival in pancreatic, pulmonary, and mammary carcinoma. Genes Cancer (2015) 0.77
Head mass in chronic pancreatitis: Inflammatory or malignant. World J Gastrointest Endosc (2015) 0.76
Utility of Contrast-Enhanced Transabdominal Ultrasonography to Diagnose Early Chronic Pancreatitis. Biomed Res Int (2015) 0.76
Pancreatic cancer in chronic pancreatitis. Indian J Surg Oncol (2015) 0.76
A resequence analysis of genomic loci on chromosomes 1q32.1, 5p15.33, and 13q22.1 associated with pancreatic cancer risk. Pancreas (2013) 0.76
TGF-β1 promotes acinar to ductal metaplasia of human pancreatic acinar cells. Sci Rep (2016) 0.76
The Presence of Interleukin-13 at Pancreatic ADM/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis. Cell Rep (2017) 0.75
Correlation between blood lipid levels and chronic pancreatitis: a retrospective case-control study of 48 cases. Medicine (Baltimore) (2014) 0.75
Metabolic disorder, inflammation, and deregulated molecular pathways converging in pancreatic cancer development: implications for new therapeutic strategies. Cancers (Basel) (2011) 0.75
Simultaneous occurrence of autoimmune pancreatitis and pancreatic cancer in patients resected for focal pancreatic mass. World J Gastroenterol (2017) 0.75
Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study. Biol Sex Differ (2016) 0.75
Early diagnosis of chronic pancreatitis: understanding the factors associated with the development of chronic pancreatitis. Fukushima J Med Sci (2017) 0.75
Legumain is activated in macrophages during pancreatitis. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Pancreatitis promotes oncogenic Kras(G12D)-induced pancreatic transformation through activation of Nupr1. Mol Cell Oncol (2014) 0.75
Insights into the genetic risk factors for the development of pancreatic disease. Therap Adv Gastroenterol (2017) 0.75
Insulin promotes proliferation and fibrosing responses in activated pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivo. Sci Rep (2017) 0.75
Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer. Cent Eur J Immunol (2017) 0.75
Imaging in pancreatic disease. Nat Rev Gastroenterol Hepatol (2016) 0.75
Association of cholesterol with risk of pancreatic cancer: a meta-analysis. World J Gastroenterol (2015) 0.75
Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer. Pancreas (2016) 0.75
Modulation of Human Peripheral Blood Mononuclear Cell Signaling by Medicinal Cannabinoids. Front Mol Neurosci (2017) 0.75
Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis. Nutrients (2017) 0.75
Loss of MTSS1 results in increased metastatic potential in pancreatic cancer. Oncotarget (2017) 0.75
Chronic Pancreatitis: A Review. Indian J Surg (2015) 0.75
Pleiotropic effect of common variants at ABO Glycosyltranferase locus in 9q32 on plasma levels of pancreatic lipase and angiotensin converting enzyme. PLoS One (2014) 0.75
Epidemiology of Recurrent Acute and Chronic Pancreatitis: Similarities and Differences. Dig Dis Sci (2017) 0.75
Stem cell-derived organoids to model gastrointestinal facets of cystic fibrosis. United European Gastroenterol J (2016) 0.75
Evaluation of neurotensin receptor 1 as a potential imaging target in pancreatic ductal adenocarcinoma. Amino Acids (2017) 0.75
Real time endoscopic ultrasound elastography and strain ratio in the diagnosis of solid pancreatic lesions. World J Gastroenterol (2017) 0.75
Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer. Oncotarget (2017) 0.75
Chronic Pancreatitis: Current Status and Challenges for Prevention and Treatment. Dig Dis Sci (2017) 0.75
Nationwide epidemiological survey of early chronic pancreatitis in Japan. J Gastroenterol (2017) 0.75
Role of Multi Detector Computed Tomography (MDCT) in Preoperative Staging of Pancreatic Carcinoma. J Clin Diagn Res (2017) 0.75
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med (2003) 11.93
Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20
Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol (2013) 4.21
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology (2004) 4.05
The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology (2013) 3.89
Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol (2004) 3.87
Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology (2007) 3.73
Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol (2009) 3.67
Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg (2010) 3.61
Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med (2012) 3.27
Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol (2006) 3.26
Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women. J Natl Cancer Inst (2003) 3.20
Smoking and colorectal cancer: a meta-analysis. JAMA (2008) 3.19
Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study. Hepatology (2010) 2.87
Comparative analysis of alcohol control policies in 30 countries. PLoS Med (2007) 2.70
Tobacco smoking and cancer: a meta-analysis. Int J Cancer (2008) 2.64
Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas (2006) 2.62
Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol (2009) 2.57
MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer (2008) 2.37
Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol (2006) 2.36
Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg (2008) 2.29
Does acute alcoholic pancreatitis precede the chronic form or is the opposite true? A histological study. J Clin Gastroenterol (2004) 2.28
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med (2012) 2.24
Assessment of risk associated with specific fatty acids and colorectal cancer among French-Canadians in Montreal: a case-control study. Int J Epidemiol (2003) 2.11
Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study. Am J Gastroenterol (2013) 2.11
Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia (2005) 2.03
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. Circulation (2005) 2.01
Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat (2006) 1.99
Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology (2007) 1.98
Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy. J Natl Cancer Inst (2007) 1.97
Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results. J Thorac Cardiovasc Surg (2011) 1.94
Four-arm robotic lobectomy for the treatment of early-stage lung cancer. J Thorac Cardiovasc Surg (2009) 1.91
Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol (2003) 1.84
A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med (2011) 1.83
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res Treat (2007) 1.82
Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer (2002) 1.78
Warm water or oil-assisted colonoscopy: toward simpler examinations? Am J Gastroenterol (2007) 1.77
Epidemiology of pancreatic cancer: an update. Dig Dis (2010) 1.75
Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis (2009) 1.75
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy. Blood (2006) 1.69
Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity. Breast Cancer Res Treat (2008) 1.62
Is response to antiviral treatment influenced by hepatitis B virus genotype? J Hepatol (2010) 1.61
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat (2010) 1.59
Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology (2003) 1.59
The harmless acute pancreatitis score: a clinical algorithm for rapid initial stratification of nonsevere disease. Clin Gastroenterol Hepatol (2009) 1.58
ABO blood group and cancer. Eur J Cancer (2010) 1.57
Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria? Eur J Cardiothorac Surg (2011) 1.56
Follow-up of exocrine pancreatic function in type-1 diabetes mellitus. Digestion (2005) 1.56
High serum creatinine in acute pancreatitis: a marker for pancreatic necrosis? Am J Gastroenterol (2009) 1.52
Pathological features and survival outcomes of very young patients with early breast cancer: how much is "very young"? Breast (2013) 1.51
Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function. Can J Cardiol (2012) 1.51
High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer (2003) 1.49
Chromogranin A: is it a useful marker of neuroendocrine tumors? J Clin Oncol (2007) 1.49
Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus. Pancreas (2008) 1.48
Evolution of emphysema in relation to smoking. Eur Radiol (2009) 1.47
Polymorphism in the CYP2D6 tamoxifen-metabolizing gene influences clinical effect but not hot flashes: data from the Italian Tamoxifen Trial. J Clin Oncol (2006) 1.47
Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol (2005) 1.47
Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol (2004) 1.46
Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg (2005) 1.45
Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer (2008) 1.45
Environmental factors and risk of pancreatic cancer. Pancreatology (2003) 1.45
Natural history of acute pancreatitis: a long-term population-based study. Am J Gastroenterol (2009) 1.44
Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis. J Gastroenterol Hepatol (2008) 1.44
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J Hepatol (2009) 1.43
Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol (2005) 1.42
Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol (2004) 1.42
Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am J Clin Nutr (2008) 1.41
Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer (2005) 1.40
Fat Grafting after Invasive Breast Cancer: A Matched Case-Control Study. Plast Reconstr Surg (2017) 1.38
Risk factors for pancreatic cancer. J Cell Biochem (2005) 1.35
Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies. Ann Surg Oncol (2011) 1.33
Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer (2009) 1.28
Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study. Am J Gastroenterol (2009) 1.25
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J Clin Microbiol (2006) 1.24
Pathological assessment of pericolonic tumor deposits in advanced colonic carcinoma: relevance to prognosis and tumor staging. Mod Pathol (2007) 1.23
Vitamin D and skin cancer: a meta-analysis. Eur J Cancer (2008) 1.22
Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe. Eur Addict Res (2010) 1.22
Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Biomarkers Prev (2005) 1.21
How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology. Int J Radiat Oncol Biol Phys (2012) 1.21
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes. Breast Cancer Res (2014) 1.20
Ultrasound-guided vacuum-assisted core breast biopsy: experience with 406 cases. Breast Cancer Res Treat (2006) 1.20
Smoking is underrecognized as a risk factor for chronic pancreatitis. Pancreatology (2011) 1.19